Total Payments
$369,378
2024 Payments
$219,230
Companies
33
Transactions
763
Medicare Patients
589
Medicare Billing
$47,071
Payment Breakdown by Category
Other$259,676 (70.3%)
Consulting$57,464 (15.6%)
Travel$33,520 (9.1%)
Food & Beverage$18,291 (5.0%)
Education$383.79 (0.1%)
Gifts$43.57 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $259,424 | 87 | 70.2% |
| Consulting Fee | $57,464 | 20 | 15.6% |
| Travel and Lodging | $33,520 | 89 | 9.1% |
| Food and Beverage | $18,291 | 559 | 5.0% |
| Education | $383.79 | 6 | 0.1% |
| Honoraria | $251.97 | 1 | 0.1% |
| Gift | $43.57 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Incyte Corporation | $149,216 | 201 | $0 (2024) |
| Galderma Laboratories, L.P. | $69,164 | 87 | $0 (2024) |
| GENZYME CORPORATION | $41,380 | 41 | $0 (2024) |
| ABBVIE INC. | $29,789 | 73 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $18,889 | 15 | $0 (2024) |
| PFIZER INC. | $18,107 | 24 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $11,298 | 45 | $0 (2024) |
| Arcutis Biotherapeutics, Inc. | $8,755 | 27 | $0 (2024) |
| Eli Lilly and Company | $5,857 | 5 | $0 (2024) |
| Dermavant Sciences, Inc. | $3,346 | 43 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $219,230 | 379 | Incyte Corporation ($62,573) |
| 2023 | $123,800 | 240 | Incyte Corporation ($62,320) |
| 2022 | $25,839 | 124 | Incyte Corporation ($24,323) |
| 2021 | $486.62 | 19 | Amgen Inc. ($152.30) |
| 2020 | $21.90 | 1 | DERMIRA, INC. ($21.90) |
All Payment Transactions
763 individual payment records from CMS Open Payments — Page 1 of 31
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | Verrica Pharmaceuticals Inc. | YCANTH (Drug) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: DERMATOLOGY | ||||||
| 12/20/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: Immunology | ||||||
| 12/19/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $1,725.00 | General |
| 12/19/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $11.75 | General |
| Category: Dermatology | ||||||
| 12/19/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $2.77 | General |
| Category: Dermatology | ||||||
| 12/18/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $9.64 | General |
| Category: Dermatology | ||||||
| 12/17/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: DERMATOLOGY | ||||||
| 12/13/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $115.87 | General |
| Category: Dermatology | ||||||
| 12/13/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $5.95 | General |
| 12/11/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $23.30 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: Immunology | ||||||
| 12/11/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: DERMATOLOGY | ||||||
| 12/10/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: Dermatology | ||||||
| 12/10/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $3.58 | General |
| Category: Dermatology | ||||||
| 12/09/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $29.05 | General |
| Category: Immunology | ||||||
| 12/06/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: Inflammation & Immunology | ||||||
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $11.98 | General |
| Category: Immunology | ||||||
| 12/04/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $130.03 | General |
| Category: Dermatology | ||||||
| 12/04/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: Dermatology | ||||||
| 12/04/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/04/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: ONCOLOGY | ||||||
| 12/04/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $8.08 | General |
| 12/02/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $674.10 | General |
| 12/02/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $24.16 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 155 | 256 | $39,482 | $13,343 |
| 2022 | 10 | 306 | 460 | $83,186 | $26,177 |
| 2021 | 7 | 116 | 138 | $41,359 | $6,507 |
| 2020 | 1 | 12 | 16 | $5,056 | $1,045 |
Total Patients
589
Total Services
870
Medicare Billing
$47,071
Procedure Codes
25
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 28 | 52 | $13,930 | $4,707 | 33.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 40 | 55 | $9,645 | $3,510 | 36.4% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 18 | 24 | $5,371 | $1,958 | 36.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 15 | 16 | $3,886 | $1,127 | 29.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 24 | 26 | $3,439 | $952.92 | 27.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 15 | 20 | $2,381 | $758.86 | 31.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 15 | 63 | $829.08 | $329.64 | 39.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 45 | 53 | $12,775 | $5,993 | 46.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 53 | 62 | $12,179 | $4,897 | 40.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 22 | 22 | $8,348 | $3,302 | 39.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 26 | 27 | $10,460 | $2,728 | 26.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 29 | 30 | $9,763 | $2,400 | 24.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 32 | 32 | $8,081 | $2,296 | 28.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 34 | 35 | $8,537 | $1,569 | 18.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 23 | 24 | $3,367 | $1,173 | 34.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 28 | 161 | $6,607 | $963.08 | 14.6% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 14 | 14 | $3,068 | $854.58 | 27.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 30 | 37 | $12,614 | $2,363 | 18.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 18 | 18 | $9,624 | $1,974 | 20.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 19 | 19 | $4,587 | $974.03 | 21.2% |
| 17000 | Destruction of skin growth | Office | 2021 | 12 | 12 | $3,168 | $475.85 | 15.0% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 12 | 12 | $2,961 | $393.66 | 13.3% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 14 | 15 | $6,930 | $297.73 | 4.3% |
| 17003 | Destruction of 2-14 skin growths | Office | 2021 | 11 | 25 | $1,475 | $27.80 | 1.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 12 | 16 | $5,056 | $1,045 | 20.7% |
About Dr. Karan Lal, DO
Dr. Karan Lal, DO is a Dermatology healthcare provider based in Scottsdale, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/25/2016. The National Provider Identifier (NPI) number assigned to this provider is 1679928832.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Karan Lal, DO has received a total of $369,378 in payments from pharmaceutical and medical device companies, with $219,230 received in 2024. These payments were reported across 763 transactions from 33 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($259,424).
As a Medicare-enrolled provider, Lal has provided services to 589 Medicare beneficiaries, totaling 870 services with total Medicare billing of $47,071. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Other Specialties Dermatology, MOHS-Micrographic Surgery
- Location Scottsdale, AZ
- Active Since 04/25/2016
- Last Updated 02/21/2024
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1679928832
Products in Payments
- OPZELURA (Drug) $139,111
- DUPIXENT (Biological) $43,923
- RINVOQ (Biological) $26,048
- SPEVIGO (Drug) $18,874
- LITFULO (Drug) $17,796
- Winlevi (Drug) $10,346
- Zoryve (Drug) $8,731
- AKLIEF (Drug) $7,995
- OLUMIANT (Drug) $5,673
- VTAMA (Drug) $3,346
- YCANTH (Drug) $2,700
- Recell (Device) $1,000
- TALTZ (Drug) $506.38
- Sotyktu (Drug) $483.06
- TREMFYA (Drug) $371.28
- SKYRIZI (Biological) $308.67
- ILUMYA (Biological) $283.95
- Otezla (Drug) $279.63
- COSENTYX (Drug) $225.65
- ADBRY (Biological) $208.45
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Scottsdale
Dr. Anthony Nuara, M.d., Ph.d, M.D., PH.D
Dermatology — Payments: $442,438
Dermatology $442,438
Matthew Laffer, D.o, D.O
Dermatology — Payments: $141,722
Dermatology $141,722
Ms. Brenda Latowsky, Md, MD
Dermatology — Payments: $141,122
Dermatology $141,122
Aaron Mangold, M.d, M.D
Dermatology — Payments: $134,790
Dermatology $134,790
Dr. Gary Mccracken, M.d, M.D
Dermatology — Payments: $71,783
Dermatology $71,783
Aleksandar Sekulic, M.d, M.D
Dermatology — Payments: $38,461
Dermatology $38,461